Management of drug interactions with direct‐acting antivirals in Dutch  HIV /hepatitis C virus‐coinfected patients: adequate but not perfect | Zendy

Smolders EJ | Zendy; Smit C | Zendy; Kanter CTMM | Zendy; Dofferhoff ASM | Zendy; Arends JE | Zendy; Brinkman K | Zendy; Rijnders B | Zendy; Valk M | Zendy; Reiss P | Zendy; Burger DM | Zendy

Premium

Management of drug interactions with direct‐acting antivirals in Dutch HIV /hepatitis C virus‐coinfected patients: adequate but not perfect

Author(s) -

Smolders EJ,

Smit C,

Kanter CTMM,

Dofferhoff ASM,

Arends JE,

Brinkman K,

Rijnders B,

Valk M,

Reiss P,

Burger DM

Publication year - 2018

Publication title -

hiv medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.53

H-Index - 79

eISSN - 1468-1293

pISSN - 1464-2662

DOI - 10.1111/hiv.12570

Subject(s) - medicine , cart , regimen , coinfection , chronic hepatitis , cohort , hepatitis c virus , hepatitis c , human immunodeficiency virus (hiv) , cohort study , observational study , drug , virus , pharmacology , virology , mechanical engineering , engineering

Direct-acting antivirals (DAAs) for treatment of chronic hepatitis C virus (HCV) infection can cause drug-drug interactions (DDIs) with combination antiretroviral therapy (cART) and non-cART co-medication. We mapped how physicians manage DDIs between DAAs and co-medication and analysed treatment outcomes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research